2019–2020 herd immunity to seasonal influenza viruses prior to epidemic season and rate of severe disease cases

Cover Page

Cite item

Abstract

The aim was to analyze heard immunity against influenza viruses as well as severe course of influenza infection prior to the 2019–2020 epidemic season. Methods. Blood sera samples were collected prior to and after conducting population-wide influenza vaccination campaign at the sanitary and epidemiological centers in different regions of the Russian Federation as well as at the Siberian Federal District, respectively. Sera samples were tested by using hemagglutination inhibition (HI) assay with vaccine strains A/Brisbane/02/2018 (H1N1)pdm09, A/Kansas/14/2017 (H3N2), B/Colorado/06/2017 (Victoria lineage). Baseline clinical and autopsy materials in case of influenza infection in vaccinated patients or severe and fatal influenza cases were collected to be tested by RT-PCR at the sanitary and epidemiological centers, Rospotrebnadzor. All influenza-virus positive samples were further sent to the SRC VB “Vector”. Results. A total of 7,896 and 600 blood serum samples were collected from subjects at Siberian Federal District prior to and after the populationwide influenza vaccination campaign, respectively. Prior to the epidemic season, the proportion of individuals seropositive for the influenza A virus subtypes A/(H1N1)pdm09 and A/H3N2 exceeded 50% in most of the regions, whereas frequency of those seropositive for the influenza B virus was profoundly lower ranging from 12 to 46% in the Northwestern Federal District and Volga Federal District, respectively. After influenza vaccination, the percentage of seropositive subjects in the Siberian Federal District increased as follows: for influenza subtype A/(H1N1)pdm09 — from 66 up to 79%, influenza subtype A/H3N2 — from 68 up to 78%, and for influenza B/Victoria — from 32 up to 47%. In 2019–2020, influenza B virus more frequently caused severe infection that agrees with the herd immunity data prior to the epidemic season. However, the vast majority of the influenza cases with fatal outcome was associated with influenza virus A A/H1N1pdm09 subtype. Conclusion. Quality of influenza vaccine, especially that one intended to vaccinate risk group subjects remains a crucial issue for contemporary scientific community. The study was conducted within the framework of the State Assignments no. 1/16 and 2/18.

About the authors

T. N. Ilyicheva

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Author for correspondence.
Email: ilicheva_tn@vector.nsc.ru
ORCID iD: 0000-0002-2354-7688

Tatyana N. Ilyicheva,  PhD, MD (Biology), Associate Professor, Leading Researcher, Department of Zoonotic Infections and Influenza 

630559, Novosibirsk Region, Koltsovo

Phone: +7 383 363-47-00. Fax: +7 383 336-74-09 

Russian Federation

N. P. Kolosova

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: kolosova_np@vector.nsc.ru

PhD (Biology), Leading Researcher, Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

A. G. Durymanov

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: gavrilych51@mail.ru

Senior Researcher, Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

P. Yu. Torzhkova

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: torzhkova_pyu@vector.nsc.ru

Senior Investigator (Biologist), Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

S. V. Svyatchenko

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: svyatchenko_sv@vector.nsc.ru

Junior Researcher, Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

Y. A. Bulanovich

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: bulanovich_yua@vector.nsc.ru

Senior Investigator (Biologist), Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

E. V. Ivanova

Center for Hygiene and Epidemiology in Novosibirsk Region of Rospotrebnadzor

Email: cgnso@cn.ru

Virologist 

Novosibirsk

Russian Federation

K. I. Ivanova

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: ivanova_ki@vector.nsc.ru

Senior Investigator (Biologist), Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

A. B. Ryzhikov

State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor

Email: ryzhik@vector.nsc.ru

PhD (Biology), Head of the Department of Zoonotic Infections and Influenza 

Koltsovo, Novosibirsk Region

Russian Federation

References

  1. Ильичева Т.Н., Дурыманов А.Г., Иванова Е.В., Жирнов В.А., Епанчинцева А.В., Святченко С.В., Торжкова П.Ю., Буланович Ю.А., Рыжиков А.Б. Гуморальный иммунитет к гриппу и тяжелые случаи заболевания в эпидемическом сезоне 2018–2019 гг. // Медицинская иммунология. 2019. Т. 21, № 6. С. 1147–1154. [Ilyicheva T.N., Durymanov A.G., Ivanova E.V., Zhirnov V.A., Epanchintseva A.V., Svyatchenko S.V., Torzhkova P.Yu., Bulanovich Yu.A., Ryzhikov A.B. Humoral immunity to influenza and severe influenza cases in Russia in 2018–2019. Meditsinskaya immunologiya = Medical Immunology (Russia), 2019, vol. 21, no. 6, pp. 1147–1154. (In Russ.)] doi: 10.15789/1563-0625-2019-6-1147-1154
  2. Роспотребнадзор. Об эпидемиологической ситуации по заболеваемости гриппом и ОРВИ и ходом иммунизации населения против гриппа. 21.01.2020. [Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor). Regarding the epidemiological situation on influenza and ARVI incidence rate as well as course of influenza population-wide immunization. 21.01.2020. (In Russ.)] URL: https://rospotrebnadzor.ru/about/info/news/news_details.php?ELEMENT_ID=13498
  3. Andrew M.K., Bowles S.K., Pawelec G., Haynes L., Kuchel G.A., McNeil S.A., McElhaney J.E. Influenza vaccination in older adults: recent innovations and practical applications. Drugs Aging, 2019, vol. 36, no. 1, pp. 29–37. doi: 10.1007/s40266-018-0597-4
  4. Fulop T., Larbi A., Witkowski J.M., McElhaney J., Loeb M., Mitnitski A., Pawelec G. Aging, frailty and age-related diseases. Biogerontology, 2010, vol. 11, no. 5, pp. 547–563. doi: 10.1007/s10522-010-9287-2
  5. Ghendon Y.Z., Kaira A.N., Elshina G.A. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol. Infect., 2006, vol. 134, no. 1, pp. 71–78. doi: 10.1017/s0950268805005650
  6. Haq K., Fulop T., Tedder G., Gentleman B., Garneau H., Meneilly G.S., Kleppinger A., Pawelec G., McElhaney J.E. Cytomegalovirus seropositivity predicts a decline in the T cell but not the antibody response to influenza in vaccinated older adults independent of type 2 diabetes status. J. Gerontol. A Biol. Sci. Med. Sci., 2017, vol. 72, no. 9, pp. 1163–1170. doi: 10.1093/gerona/glw216
  7. Ilyicheva T., Durymanov A., Susloparov I., Kolosova N., Goncharova N., Svyatchenko S., Petrova O., Bondar A., Mikheev V., Ryzhikov A. Fatal cases of seasonal influenza in Russia in 2015–2016. PLoS One, 2016, vol. 11, no. 10: e0165332. doi: 10.1371/journal.pone.0165332
  8. Ilyicheva T.N., Durymanov A.G., Svyatchenko S.V., Marchenko V.Y., Sobolev I.A., Bakulina A.Y., Goncharova N.I., Kolosova N.P., Susloparov I.M., Pyankova O.G., Ryzhikov A.B., Maksyutov R.A. Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017. Arch. Virol., 2018, vol. 163, no. 10, pp. 2675–2685. doi: 10.1007/s00705-018-3904-9
  9. Jergović M., Contreras N.A., Nikolich-Žugich J. Impact of CMV upon immune aging: facts and fiction. Med. Microbiol. Immunol., 2019, vol. 208, no. 3–4, pp. 263–269. doi: 10.1007/s00430-019-00605-w
  10. Kim T.H., Johnstone J., Loeb M. Vaccine herd effect. Scand. J. Infect. Dis., 2011, vol. 43, no. 9, pp. 683–689. doi: 10.3109/00365548.2011.582247
  11. Kolosova N.P., Ilyicheva T.N., Danilenko A.V., Bulanovich J.A., Svyatchenko S.V., Durymanov A.G., Goncharova N.I., Gudymo A.S., Shvalov A.N., Susloparov I.M., Marchenko V.Y., Tregubchak T.V., Gavrilova E.V., Maksyutov R.A., Ryzhikov A.B. Severe cases of seasonal influenza in Russia in 2017–2018. PLoS One., 2019, vol. 14, no. 12: e0227382. doi: 10.1371/journal.pone.0220401
  12. Kwong J.C., Schwartz K.L., Campitelli M.A., Chung H., Crowcroft N.S., Karnauchow T., Katz K., Ko D.T., McGeer A.J., McNally D., Richardson D.C., Rosella L.C., Simor A., Smieja M., Zahariadis G., Gubbay J.B. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med., 2018, vol. 378, no. 4, pp. 345–353. doi: 10.1056/NEJMoa1702090
  13. Mertz D., Fadel S.A., Lam P.P., Tran D., Srigley J.A., Asner S.A., Science M., Kuster S.P., Nemeth J., Johnstone J., Ortiz J.R., Loeb M. Herd effect from influenza vaccination in non-healthcare settings: a systematic review of randomised controlled trials and observational studies. Euro Surveill., 2016, vol. 21, no. 42: 30378. doi: 10.2807/1560-7917.ES.2016.21.42.30378
  14. Mertz D., Kim T.H., Johnstone J., Lam P.P., Science M., Kuster S.P., Fadel S.A., Tran D., Fernandez E., Bhatnagar N., Loeb M. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ, 2013, vol. 347: f5061. doi: 10.1136/bmj.f5061
  15. Pawelec G. Immune parameters associated with mortality in the elderly are context-dependent: lessons from Sweden, Holland and Belgium. Biogerontology, 2018, vol. 19, no. 6, pp. 537–545. doi: 10.1007/s10522-017-9739-z
  16. Schaffner W., Chen W.H., Hopkins R.H., Neuzil K. Effective immunization of older adults against seasonal influenza. Am. J. Med., 2018, vol. 131, no. 8, pp. 865–873. doi: 10.1016/j.amjmed.2018.02.019
  17. Schaffner W., van Buynder P., McNeil S., Osterhaus A.D.M.E. Seasonal influenza immunisation: strategies for older adults. Int. J. Clin. Pract., 2018, vol. 72, no. 10: e13249. doi: 10.1111/ijcp.13249
  18. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., Fukuda K. Influenza-associated hospitalizations in the United States. JAMA, 2004, vol. 292, no. 11, pp. 1333–1340. doi: 10.1001/jama.292.11.1333
  19. WHO. Immunization, vaccines and biologicals: Influenza. URL: http://www.who.int/immunization/topics/influ
  20. WHO. Seasonal vaccination policies and coverage in the European Region. URL: http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/seasonal-vaccination-policies-and-coverage-in-the-european-region

Supplementary files

There are no supplementary files to display.


Copyright (c) 2021 Ilyicheva T.N., Kolosova N.P., Durymanov A.G., Torzhkova P.Y., Svyatchenko S.V., Bulanovich Y.A., Ivanova E.V., Ivanova K.I., Ryzhikov A.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies